Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
"This is crucial, given the strong link between MASH and cardiovascular, metabolic, and renal conditions, where semaglutide has already shown established health benefits." Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist, essentially acting like the natural GLP-1 hormone to help regulate key metabolic processes including reducing appetite and lowering blood sugar
Its main job is to help regulate blood sugar by prompting your pancreas to release insulin (which lowers blood sugar) and by reducing the release of glucagon (which raises blood sugar)
The new drugs will almost certainly be more expensive than those already on the market, but they should make it slightly easier for patients to access older GLP-1 drugs
Additionally, it slows down the rate at which food exits the stomach by delaying gastric emptying, which helps curb appetite and manage post-meal glucose increases
